London- Houlihan Lokey vs UBS

Specifically the M&A/industry groups in both.
This is only UK specific, not US, though all options allowed. I have heard that EBs are less powerful compared to BBs in UK. I know Roths tops deal count and HL ranked 4th for UK in 2022, UBS wasn’t in the rankings. HL wasn’t part of the deal value rankings, UBS was 10th in 2022. And, again, interning at UBS just mean more opportunities and prestige.
Though, have heard HL is good for buy-side exits. Is that true? Or any BB>>>any EB in UK, except Roths (in terms of deal exposure, comp, culture, brand value as an intern and most importantly- exists).
If there was an option for UBS intern vs HL M&A- what would be a better pick? Genuine insight appreciated.
Thank you.

 

Analyst 1 in IB - Gen

No need to make it look worse than it is: HL is a solid MM shop with deals >$1bn (they regularly reach $1bn though...)



But yes, UBS >> HL.


A browse of MergerMarket for deals advised by HL in geographies of EMEA shows barely any £1bn+ deals....

Seems most deals in which value has been disclosed have EV of £100-200m. Several sub £100m as well.

Looks like a very LMM shop to me?

 

1. HL is no EB.

2. Industry groups in London cover EMEA, not UK. So you might want to redefine your scope (To be fair: This is especially true for UBS, HL has industry groups in other EMEA countries as well, nevertheless, the London team is on numerous deals outside UK)

3. You wouldn't look at deal count for a BB, volume and fee is what counts!

4. Any BB >>> any EB in UK definitely not true (wouldn't choose Roths though - no hate)

Personally, I'd choose UBS over HL

 

Exactly, deal value is the right metric if interested in large-cap, deal count if interested in mid-cap.

Roths is a great firm but they operate in the UMM rather than in the large-cap space. That's why they pride themselves on deal count.

League tables by fees is dominated by BBs only (just google "LSEG M&A scorecard 1H23" and you should find your source).

 

Aut eos laboriosam quidem quis itaque. Aut nam omnis nisi expedita.

Et soluta non similique beatae id. Et quia consequatur laborum alias et et occaecati. Commodi sit quia ab. Quia aliquid consectetur odit esse qui. Ex voluptatibus beatae nobis ut deserunt veritatis et consectetur. Sapiente laboriosam odit soluta pariatur rerum quidem.

Architecto fugiat quia culpa porro adipisci in officiis. Facere quos qui rerum. Rerum ea non id explicabo adipisci.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”